January is Alzheimer's Awareness Month in Canada. According to the Alzheimer's Association, almost 750,000 Canadians are ...
Dementia remains one of the most pressing public health challenges of our time. Its economic burden exceeds $1 trillion ...
Retro Biosciences will back clinical trials for three drugs—including a potential Alzheimer’s disease treatment set to begin ...
But the 72-year-old Mendoza, who has not been diagnosed with Alzheimer’s, isn’t getting the exam at a doctor’s office or a clinical lab. She’s in a comfortable and familiar place, sipping Cuban coffee ...
We now have two FDA-approved disease-modifying treatments for Alzheimer's disease, and hundreds of clinical trials are ...
Preserving levels of brain glucose metabolism can both slow cognitive decline and reduces the risk of conversion to dementia.
Antimicrobials, vaccines, anti-inflammatories linked to reduced risk for Alzheimer disease and dementia; antipsychotics and diabetes drugs tied to higher risk ...
The disease afflicts nearly seven million Americans, about one in every nine people over the age of 65, making it a leading ...
Ozempic and Wegovy do the same thing as GLP-1 would normally do for you — but to enable them to treat diabetes and obesity, ...
The Alzheimer’s Foundation of America is offering scholarships of up to $5,000 to college-bound high school seniors affected ...
Lecanemab reduces toxic amyloid-β protofibrils, slowing Alzheimer’s disease progression and supporting personalised treatment ...
EXCLUSIVE - Knowing the heartbreaking moment an elderly loved-one needs residential care is a daunting and emotional time.